SENSEX NIFTY

Sanofi Aventis

Jan 06, 2016 at 11:38 | Source: PTI
In a BSE filing, Glenmark said it "has been granted tentative approval by the US Food & Drug Administration (USFDA) for its Dronedarone Tablets, 400 mg, the generic version of Multaq Tablet, 400 mg of Sanofi-Aventis US LLC."
Jan 06, 2016 at 11:18 | Source: Moneycontrol.com
Glenmark Pharmaceuticals Inc, USA has been granted tentative approval by the USFDA for its Dronedarone tablets, 400 mg, the generic version of Multaq tablets, 400 mg of Sanofi-Aventis US LLC.
Jan 06, 2016 at 10:59 | Source: Moneycontrol.com
The company has received an approval for its Dronedarone tablets, 400 mg, the generic version of Multaq tablets, 400 mg of Sanofi-Aventis US LLC.
Dec 08, 2015 at 15:09 | Source: Moneycontrol.com
"Unichem has received ANDA approval from the United States Food and Drug Administration (USFDA) for Irbesartan tablets USP 75 mg, 150 mg and 300 mg," the pharma company said in its filing. The drug is equivalent to Avapro tablets of Sanofi-aventis US LLC.
Nov 20, 2015 at 21:32 | Source: PTI
"The transaction has been completed on November 20, 2015, upon fulfillment of the conditions precedent and the company has received the entire sale consideration of Rs 1110 million from the purchaser," Sanofi India said in a BSE filing.
Oct 11, 2015 at 11:27 | Source: PTI
The government is likely to commission a study soon to assess the impact of foreign direct investment in existing pharmaceutical companies in view of concerns expressed on the issue by a Parliamentary panel.
Jul 21, 2015 at 20:31 | Source: PTI
Standalone total income from operations also rose to Rs 549.7 crore for the quarter ended June 30, 2015 as against Rs 505.8 crore for the same period year ago, Sanofi India said in a filing to the BSE.
Sep 23, 2013 at 09:56 | Source: Moneycontrol.com
Genzyme, a fully-owned subsidiary of drug major Sanofi-Aventis, alleged that the Indian drug maker infringed patents of its blockbuster cancer drug Mozobil on three counts.
Sep 22, 2013 at 13:58 | Source: PTI
In its petition filed in the District Court of Delaware, Genzyme alleged that DRL intimated though a letter that it had submitted an Abbreviated New Drug Application with US FDA seeking approval to engage in the commercial manufacture, importation, use, and sale of 20 mg/ml Plerixafor injection as a generic version of Mobozil drug.
Sep 16, 2013 at 15:54 | Source: Moneycontrol.com
Pharma major, Lupin, announced today that it has received final approval for its Zolpidem Tartrate Extended-release tablets USP, 6.25 mg and 12.5 mg from the United States Food and Drugs Administration (FDA) to market a generic version of Sanofi Aventis, US, LLCs (Sanofi) Ambien CR Extended-release tablets, 6.25 mg and 12.5 mg.
Messages on Sanofi Aventis »

Poppee55

Platinum Member

734 Followers

Sun Pharma  

Sun Pharma has got tentative USFDA approvals for fexofenadine pseudoephedrine hydrochlorides combination which is currently sold under brand name of Allegra D (annual sales approximately US$400mn). Sun Pharma has settlement with innovator Sanofi Aventis to launch the product before patent expiry

10.05 AM Apr 4th 2014

Web Messenger

Platinum Member

348125 Followers

News Now  

Source:VC Circle - Sanofi Aventis is investing Rs 755 crore to buy out the remaining minority shareholders of Shantha Biotechnics Ltd and fund its further expansion plans, spokesperson of the French drugmaker told VCCircle. This follows the nod from the Foreign

12.05 PM Nov 2nd 2013

Web Messenger

Platinum Member

348125 Followers

Lupin  

Source:VC Circle - Mumbai-based pharma major Lupin Ltd has received the final approval from US Food and Drug Administration (FDA) to manufacture and market in the US a generic version of Sanofi Aventis' Ambien CR Extended-release tablets, used in treating sleep 

6.18 PM Sep 18th 2013

Firstpost

Platinum Member

1139 Followers

Lupin  

Source:FirstPost - New Delhi: Drug major Lupin today said it has received US health regulator`s approval to market a generic version of Sanofi Aventis` Ambien CR Extended-release tablets, used in treating sleep disorders, in the American market.The company has received final approval from the US

6.15 PM Sep 16th 2013

Web Messenger

Platinum Member

348125 Followers

Lupin  

Source:The Hindu BusinessLine - Lupin has received the US health regulator’s approval to market a generic version of Sanofi Aventis’ Rifadin capsules, used to treat tuberculosis, in the American market. The company’s US-based subsidiary Lupin Pharmaceuticals Inc has received final approval from

11.07 AM Aug 24th 2013

MMB Moderator

Platinum Member

2942 Followers

Sun Pharma  

to the drug regulator`s website. The company had earlier received tentative approval for the drug from the US FDA in 2010. Riluzole is a generic version of Sanofi Aventis` Rilutek. Sanofi sold US rights for Rilutek and a few other drugs to Covis Pharma earlier this year. Sun Pharma`s Indian rival Glenmark

12.26 PM Jun 22nd 2013

k.v.renga

Platinum Member

965 Followers

Sun Pharma  

for the drug from the US FDA in 2010. Riluzole is a generic version of Sanofi Aventis` Rilutek. Sanofi sold US rights for Rilutek and a few other drugs to Covis Pharma earlier this year. Sun Pharma`s Indian rival Glenmark had also announced earlier this week that its US generics arm received FDA approval

8.33 PM Jun 21st 2013

Mikki Mouse

Platinum Member

57 Followers

Sterling Bio  

or even years to get it revoked and Indian companies like Lupin and Aurobindo have got clearance from the USFDA after getting a warning or an import alert (see Under the FDA Scanner). Even global pharma majors are not exempt from this. For instance, Novartis Intl AG and Sanofi Aventis Deutschland GmbH got

1.06 PM May 27th 2013

Web Messenger

Platinum Member

348125 Followers

Other Market Topics  

Source:DNA India - In a landmark judgment, the Andhra Pradesh High Court (APHC) on Friday ruled that the French drugmaker Sanofi Aventis, which (by buying another French firm ShanH) had acquired a 90% stake in the Hyderabad-based vaccine-maker Shantha Biotech in 2009, need not pay tax in India

4.04 PM Feb 16th 2013

Web Messenger

Platinum Member

348125 Followers

Lupin  

Source:Business Standard - Lupin Pharmaceuticals has received approval for its Irbesartan tablets, used for treating hypertension, from US Food and Drugs Administration (USFDA). The tablets are available in 75-300 mg strengths and are the AB-rated generic equivalent of Sanofi Aventis`s Avapro

1.16 PM Oct 18th 2012

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.